SCHEMBL12984089

SCHEMBL12984089

COC[C@@H]1COCCN1c1nccc(C)c1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.39
▸ CRHR1 P34998 1/20 0.38
▸ MTOR P42345 3/20 0.38
▸ PDK1 Q15118 2/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ PDK3 Q15120 1/20 0.38
▸ HCRTR1 O43613 3/20 0.35
▸ HCRTR2 O43614 3/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ USP19 O94966 1/20 0.34
▸ GABRA1 P14867 2/20 0.33
▸ PIK3CA P42336 2/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ NUDT1 P36639 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12983843 1.00 IDH1 (0.39) IDH1CRHR1MTORPDK1PDK2
SCHEMBL12983283 0.89 MEN1 (0.35) CRHR1MTORHCRTR1HCRTR2GABRA1
SCHEMBL12984198 0.87 IRAK4 (0.41) MTORHCRTR1HCRTR2GABRA1PIK3CA
SCHEMBL12983675 0.76 FFAR2 (0.44) PDK1HRH3
SCHEMBL12983861 0.76 FFAR2 (0.44) PDK1HRH3
SCHEMBL12983593 0.74 CHRM4 (0.39) HCRTR1HCRTR2
SCHEMBL13163110 0.70 PDK1 (0.39) IDH1CRHR1MTORPDK1PDK2
SCHEMBL13634351 0.70 PDK1 (0.38) IDH1MTORPDK1PDK2PDK3
SCHEMBL3435910 0.70 PDK1 (0.38) IDH1MTORPDK1PDK2PDK3
SCHEMBL12983867 0.70 IDH1 (0.40) IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278103-B2 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators Grünenthal GmbH (DE) 2016-03-08 — — US disclosed
US-9168259-B2 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators Grünenthal GmbH (DE) 2015-10-27 — — US disclosed
US-20140213569-A1 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators GRUNENTHAL GMBH (DE) 2014-07-31 — — US disclosed
US-8552200-B2 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-10-08 — — US disclosed
US-20120258947-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2012-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213569-A1 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators KCNQ2, KCNQ1, KCNQ3 IDH1 944/4885CRHR1 4783/4885MTOR 2678/4885
US-20120258947-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS KCNQ2, KCNQ1, KCNQ3 IDH1 944/4885CRHR1 4783/4885MTOR 2678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback